GameChangers: SMART therapy for Asthma

GameChangers: SMART therapy for Asthma

New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve symptoms and decrease the need for healthcare visits. But what is the latest data on SMART therapy and what are the barriers to its use?

The GameChanger: SMART therapy should be the standard of care for most asthma patients.

Upon successful completion of this course, learners should be able to:
1. Describe the latest information concerning SMART therapy in asthma.
2. Discuss how healthcare workers can decrease barriers and increase access to SMART therapy.

Geoffrey C. Wall, PharmD, FCCP, BCPS, CG
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences

Dr. Wall is a member of the Janssen Speaker’s Bureau. All relevant financial relationships have been mitigated.

Jake Galdo, PharmD, MBA, BCPS, BCGP

Dr. Galdo’s spouse is an employee at Eli Lilly currently. All relevant financial relationships have been mitigated. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Release Date: May 6, 2024
Planned Expiration Date: May 6, 2025

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.  

Universal Activity Number (UAN): 0107-0000-24-165-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


0h 30m

Topic Designator

Disease State/Drug Therapy



ACPE Topic

01 Drug Therapy





Release Date






ACPE Number


This course is in our subscription.